Bioxytran, Inc.
BIXT
$0.02
$0.005.42%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.87% | 10.17% | 10.29% | 11.02% | 28.87% |
| Total Depreciation and Amortization | 134.92% | 17.95% | 13.92% | 2.27% | -30.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | 1,032.36% | 2,059.33% |
| Total Other Non-Cash Items | 209.02% | 48.75% | 306.89% | 6.78% | -34.67% |
| Change in Net Operating Assets | 36.39% | -13.58% | -26.85% | -49.36% | -56.49% |
| Cash from Operations | -96.18% | -34.46% | -36.11% | -18.47% | 28.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.56% | -34.23% | 26.95% | -16.74% | -44.72% |
| Cash from Investing | 25.56% | -34.23% | 26.95% | -16.74% | -44.72% |
| Total Debt Issued | -87.00% | -60.11% | -0.77% | 91.91% | 335.31% |
| Total Debt Repaid | -301.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 828.10% | 596.83% | -87.59% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 128.56% | 136.76% | 168.71% | 28.78% | -23.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,791.26% | 8,291.07% | 2,515.31% | 55.92% | 67.51% |